| Bioactivity | AJM 290 is a Trx-1 inhibitor. AJM 290 is an inhibitor of the HIF-1α COOH-terminal transactivation domain, and blocks HIF-1 binding to DNA[1]. |
| CAS | 840474-95-5 |
| Formula | C20H14FNO4S |
| Molar Mass | 383.39 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Martin AR,et al. Hypoxia inducible factor down-regulation, cancer and cancer stem cells (CSCs): ongoing success stories. Medchemcomm. 2016 Oct 19;8(1):21-52. |
AJM 290
CAS: 840474-95-5 F: C20H14FNO4S W: 383.39
AJM 290 is a Trx-1 inhibitor. AJM 290 is an inhibitor of the HIF-1α COOH-terminal transactivation domain, and blocks HI
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.